MedTrace Logo

A Novel Diet-Phenotype Interaction Affecting Body Weight

NCT01303757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2016-02-09

No results posted yet for this study

Summary

The primary aim of the study is to examine insulin secretion as an effect modifier of the efficacy of a low-fat vs. low-glycemic load diet for weight loss among overweight/obese young adults in an 18-month, prospectively stratified, multi-center randomized controlled trial.

Conditions

Interventions

BEHAVIORAL

Dietary counselling

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Broad Institute of MIT and Harvard

    collaborator OTHER

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Cara B Ebbeling, PhD · Boston Children's Hospital

  • David S Ludwig, MD, PhD · Boston Children's Hospital

  • Leslie Fischer, PhD · UNC Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01303757 on ClinicalTrials.gov